drugset / Trial / NCT00626275
Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of ADL5859 in relieving pain associated with rheumatoid arthritis (RA) compared with placebo and naproxen (similar to Aleve®). A second objective is to see whether the effect of ADL5859 differs after a single dose compared with multiple doses.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADL5859 | Small molecule | 100 mg | Oral |
| Subject | ADL5859 | Small molecule | 200 mg | Oral |
| Comparator | Naproxen | Small molecule | 500 mg | Oral |